(Abst.) Gilenya vs. Tecfidera in MS...
(Abst.) Gilenya vs. Tecfidera in MS...
Posted by
agate
on 08 Jun, 2018 21:02
From PubMed, June 8, 2018--"Fingolimod vs. dimethyl fumarate in multiple sclerosis: A real-world propensity score-matched study":
Fingolimod vs dimethyl fumarate in multiple sclerosis: A real-world propensity score-matched study - PubMed
This study provides Class IV evidence that for patients with RRMS, DMF and FNG have comparable efficacy in treatment-naive patients and that FNG is superior to DMF in patients switching from self-i...
PubMed
· ncbi.nlm.nih.gov
Are you sure?
Confirm
Cancel
Are you sure?
Confirm
Cancel
Go to page
:
1
Navigation
Common actions
Home
Login
Register
Search
Recent Posts